A study to assess the efficacy, tolerability, and safety of a new oral formulation of Sandimmun--Sandimmun Neoral--in stable renal transplant patients.
Department of Transplantation, Latvian Medical Academy, Riga, Latvia.
R
R
Rosental
J
J
Bicans
R
R
Berzina
L
L
Zezina
D000328:Adult; D002985:Clinical Protocols; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012449:Safety
D007166:Immunosuppressive Agents; D016572:Cyclosporine